Back
Texas Capital Bancshares Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
66
TCBI
Texas Capital Bancshares
Last Price:
71.99
Seasonality Move:
9.56%
Sell
49
RARE
Ultragenyx Pharmaceutical
Last Price:
58.74
Seasonality Move:
-0.7%
Buy
66
Texas Capital Bancshares (TCBI)
is a Buy
Is Texas Capital Bancshares a Buy, Sell or Hold?
- The current Texas Capital Bancshares [TCBI] share price is $73.92. The Score for TCBI is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- TCBI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $58.77. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCBI Stock Price Chart
What is Texas Capital Bancshares's stock price today?
-
The Texas Capital Bancshares share price today is $73.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCBI is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $58.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
TCBI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.32 | Buy |
| Relative Strength Index (14 RSI): | 74.52 | Buy |
| Chaikin Money Flow: | 162455 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.46 - 70.14) | Buy |
| Bollinger Bands (100): | (58.38 - 66.6) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.9 | Buy |
| Relative Strength Index (14 RSI): | 65.66 | Buy |
| Chaikin Money Flow: | -154927 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.53 - 58.27) | Buy |
| Bollinger Bands (100): | (39.73 - 52.87) | Buy |
TCBI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.41 | Buy |
| 20-day SMA: | 68.03 | Buy |
| 50-day SMA: | 65.33 | Buy |
| 200-day SMA: | 61.32 | Buy |
| 8-day EMA: | 70.83 | Buy |
| 20-day EMA: | 68.27 | Buy |
| 50-day EMA: | 65.47 | Buy |
| 200-day EMA: | 61.65 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.87 | Buy |
| 20-day SMA: | 57.08 | Buy |
| 50-day SMA: | 51.49 | Buy |
| 200-day SMA: | 46.42 | Buy |
| 8-day EMA: | 57.94 | Buy |
| 20-day EMA: | 56.47 | Buy |
| 50-day EMA: | 52.53 | Buy |
| 200-day EMA: | 46.74 | Buy |
Texas Capital Bancshares Earnings Growth & TCBI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.32 per share, a decrease this year of $0.47 per share, and an increase next year of $1.20 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Texas Capital Bancshares Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||